Drug profile · INN
propranolol
APO-PROPRANOLOL
propranolol (APO-PROPRANOLOL) is a beta-1 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.
EMA: approved TGA: approved Cardiovascular system (C07) C07AA05
Patents linked 1
Pipeline programs 15
News articles 0
Drug details — propranolol
- Class
- Cardiovascular system (C07)
- Route
- —
- Patents
- 1
- Programs
- 15
- Data quality
- 0.83
Quick answer
propranolol (APO-PROPRANOLOL) is a beta-1 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.
Key facts
INN propranolol
Brand APO-PROPRANOLOL
Mechanism Beta-1 adrenergic receptor antagonist
Therapeutic class Cardiovascular system (C07)
ATC code C07AA05
Originator Alphapharm Pty Ltd
Mechanism of action
Beta-1 adrenergic receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is propranolol?
propranolol (APO-PROPRANOLOL) is a beta-1 adrenergic receptor antagonist. Associated with Alphapharm Pty Ltd.
What is the brand name for propranolol?
APO-PROPRANOLOL is a marketed brand name for propranolol. Check FDA Drugs@FDA for the current US label holder and prescribing information.